Trends in Biochemical Sciences
ReviewThe Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Section snippets
The Ras-ERK pathway
Extracellular signal-regulated kinase (ERK) is a mitogen-activated protein kinase (MAPK) that functions as the major effector of the Ras oncoprotein. MAPK pathways consist of an initial GTPase-regulated kinase (MAPKKK) that phosphorylates and activates an intermediate kinase (MAPKK) that, in turn, phosphorylates and activates an effector kinase (MAPK; Box 1). In the ERK-MAPK pathway, these components are the Ras GTPase and the protein kinases Raf, MEK and ERK (Figure 1a). Ras and the ERK-MAPK
Ras-ERK and PI3K-mTORC1 signaling dynamics
The intensity and duration of pathway activation are regulated by the strength of the stimulus and by feedback loops. The agonists involved in Ras-ERK activation overlap only partially with those that signal to PI3K-mTORC1. Phorbol 12-myristate 13-acetate (PMA) is generally a strong activator of the Ras-ERK pathway. By contrast, insulin and insulin growth factor 1 (IGF1) are weaker Ras-ERK activators, but strong PI3K-mTORC1 activators 9, 10. However, the degree of pathway activation by specific
Mechanisms of pathway integration
One of the first hints of Ras-ERK and PI3K-mTORC1 pathway integration arose during the early 1990s when our laboratory described both PI3K-dependent and -independent inputs into p70S6K activation [16]. In the intervening years, many mechanisms and modes of cross-talk have been uncovered. These include cross-inhibition, cross-activation, and pathway convergence on substrates (Box 2).
Whereas some of the kinases (Raf, MEK, and mTORC1) involved in these pathways have very narrow substrate
AGC kinase promiscuity
The Ras-ERK and PI3K-mTOR pathways additionally converge via AGC kinase promiscuity. The N-terminal kinase domain of RSKs and AKT, S6K, SGK, and PKC are all AGC kinases that share a similar architecture and a requirement for PDK1 phosphorylation of their activation loop [18]. The AKT–PDK1 interaction requires PDK1 interaction with PIP3 at the plasma membrane. By contrast, RSK, S6K, SGK, and PKC interact with PDK1 in the cytosol via their phosphorylated hydrophobic motifs 3, 18. When the
Therapeutic inhibition of Ras-ERK and PI3K-mTORC1
As major regulators of cell survival, proliferation, metabolism, and motility, the Ras-ERK and PI3K-mTORC1 pathways are commonly activated during oncogenesis. Owing to cross-activation and pathway convergence, the resulting activation of Ras-ERK and PI3K-mTOR signaling could theoretically facilitate the development of resistance to therapeutics targeting only one pathway. Indeed, concurrent KRAS/BRAF and PI3K/PTEN mutations reduce the cytostatic response of cancer cell lines to AKT and mTOR
Concluding remarks
The Ras-ERK and PI3K-mTORC1 pathways represent key mechanisms for cells to regulate cell survival, proliferation and motility. In addition to their independent signaling programs that provide compensatory mechanisms, the pathways cross-talk extensively and regulate each other both positively and negatively. Encouragingly, co-inhibition of both pathways has been successful in reducing tumor growth in xenograft cancer models and, importantly, in genetically engineered mouse models 97, 98. The
Acknowledgments
This work was funded by Susan G. Komen for the Cure (to M.C.M.) and the National Cancer Institute (NCI) grant R37CA46595 (to J.B.). J.B. is an Established Investigator of the LAM Foundation. We apologize for the fact there are many primary research papers and excellent reviews that we were unable to cite due to space limitations.
References (100)
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
Mol. Cell
(2010)Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes
Cell. Signal.
(2006)- et al.
Cell signaling by receptor tyrosine kinases
Cell
(2010) ERK negatively regulates the epidermal growth factor-mediated interaction of Gab1 and the phosphatidylinositol 3-kinase
J. Biol. Chem.
(2002)Regulation of Raf-Akt Cross-talk
J. Biol. Chem.
(2002)Negative regulation of the serine/threonine kinase B-Raf by Akt
J. Biol. Chem.
(2000)- et al.
Protein kinase A blocks Raf-1 activity by stimulating 14-3-3 binding and blocking Raf-1 interaction with Ras
J. Biol. Chem.
(2003) The activation of phosphatidylinositol 3-kinase by Ras
Curr. Biol.
(1994)Activation of phosphoinositide 3-kinase gamma by Ras
Curr. Biol.
(2002)ERK1/2 phosphorylate Raptor to promote Ras-dependent activation of mTOR complex 1 (mTORC1)
J. Biol. Chem.
(2011)
Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation
J. Biol. Chem.
The extracellular signal-regulated kinase pathway regulates the phosphorylation of 4E-BP1 at multiple sites
J. Biol. Chem.
4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors
Cancer Cell.
KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals
Mol. Cell
KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity
Cell Metab.
AKT/PKB signaling: navigating downstream
Cell
Phosphorylation of the transcription factor forkhead family member FKHR by protein kinase B
J. Biol. Chem.
Negative regulation of the forkhead transcription factor FKHR by Akt
J. Biol. Chem.
Rsk1 mediates a MEK-MAP kinase cell survival signal
Curr. Biol.
p90(RSK) blocks bad-mediated cell death via a protein kinase C-dependent pathway
J. Biol. Chem.
Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A
Mol. Cell
Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)
Cell
The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells
Cancer Cell
Evidence that Ser87 of BimEL is phosphorylated by Akt and regulates BimEL apoptotic function
J. Biol. Chem.
Determination of the specific substrate sequence motifs of protein kinase C isozymes
J. Biol. Chem.
Crystal structure of glycogen synthase kinase 3 beta: structural basis for phosphate-primed substrate specificity and autoinhibition
Cell
Role of protein kinase B and the MAP kinase cascade in mediating the EGF-dependent inhibition of glycogen synthase kinase 3 in Swiss 3T3 cells
FEBS Lett.
Differential regulation of glycogen synthase kinase-3 beta by protein kinase C isotypes
J. Biol. Chem.
Differential regulation of glycogen synthase kinase 3beta by insulin and Wnt signaling
J. Biol. Chem.
The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro
FEBS Lett.
mTOR/S6K1 and MAPK/RSK signaling pathways coordinately regulate estrogen receptor alpha serine 167 phosphorylation
FEBS Lett.
Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization
J. Biol. Chem.
Phosphorylation of p27Kip1 at threonine 198 by p90 ribosomal protein S6 kinases promotes its binding to 14-3-3 and cytoplasmic localization
J. Biol. Chem.
mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation
Mol. Cell
Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin alpha during G1 and prevents nuclear re-entry
J. Biol. Chem.
Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration
Exp. Cell Res.
The 70 kDa S6 kinase complexes with and is activated by the Rho family G proteins Cdc42 and Rac1
Cell
mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events
Cell
RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation
J. Biol. Chem.
Ribosomal protein S6 phosphorylation: from protein synthesis to cell size
Trends Biochem. Sci.
p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling
J. Biol. Chem.
Ran-binding protein 3 phosphorylation links the Ras and PI3-kinase pathways to nucleocytoplasmic transport
Mol. Cell
A method to identify serine kinase substrates Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain
J. Biol. Chem.
Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K
Cancer Cell
Integrating signals from RTKs to ERK/MAPK
Oncogene
Mitogenic signaling pathways induced by G protein-coupled receptors
J. Cell. Physiol.
The RSK family of kinases: emerging roles in cellular signalling
Nat. Rev. Mol. Cell Biol.
MAP kinase signalling pathways in cancer
Oncogene
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition
Oncogene
New insights into mTOR signaling: mTORC2 and beyond
Sci. Signal.
Cited by (1335)
Expression and in vitro effect of phoenixin-14 on the porcine ovarian granulosa cells
2024, Reproductive BiologyPotentiating sorafenib efficacy against hepatocellular carcinoma via a carrier-free nanomedicine of artesunate prodrug
2024, Smart Materials in MedicineResearch progress on traditional Chinese medicine-induced apoptosis signaling pathways in ovarian cancer cells
2024, Journal of Ethnopharmacology